Marco Virgolin

About

Marco Virgolin is the Head of AI at InSilicoTrials Technologies in the Netherlands. His research areas include pediatric rare disease drug development, symbolic regression, and the use of synthetic data in healthcare and drug development. He has published extensively on enhancing clinical trials, regulatory frameworks, and robust counterfactual explanations. His recent work emphasizes the integration of human insights into machine learning models.